ABSTRACT
We aimed, in this study, to determine the distribution of α-1 AR subtypes in rat and human pelvis and calyces, and to evaluate, by comparing these two species, the possibility of rats to be used as models for humans. Twenty patients with renal carcinoma were included into the study. The patients underwent radical nephrectomy for renal cell carcinoma (RCC). After nephrectomy, specimens were evaluated and excisional biopsies from healthy pelvis and calyces tissues were performed. When pathology confirmed the non-invasion of RCC, specimen was included into the study. A total of 7 adult Wistar Albino (250-300 g) female rats were used in this study. Specimens included renal pelvis and calyces. All specimens were evaluated under light microscope histopathologically. The concentrations of the receptor densities did not differ between the two groups. With the demonstration of the α receptors in rat kidneys and calyces, many receptor-based studies concerning both humans and rats can take place. Novel medication targeting these subtypes -in this matter α1A and α1D for renal pelvis and calyces- may be helpful for expulsive therapy and/or pain relief. With the demonstration of similar receptor densities between human and rat tissues, rat model may be useful for α-receptor trials for renal pelvis and calyces.
Subject(s)
Kidney Calices/chemistry , Kidney Pelvis/chemistry , Models, Animal , Receptors, Adrenergic, alpha/analysis , Animals , Biopsy , Carcinoma, Renal Cell/chemistry , Female , Humans , Immunohistochemistry , Kidney Neoplasms/chemistry , Nephrectomy , Rats, Wistar , Reproducibility of ResultsABSTRACT
We aimed, in this study, to determine the distribution of α-1 AR subtypes in rat and human pelvis and calyces, and to evaluate, by comparing these two species, the possibility of rats to be used as models for humans. Twenty patients with renal carcinoma were included into the study. The patients underwent radical nephrectomy for renal cell carcinoma (RCC). After nephrectomy, specimens were evaluated and excisional biopsies from healthy pelvis and calyces tissues were performed. When pathology confirmed the non-invasion of RCC, specimen was included into the study. A total of 7 adult Wistar Albino (250-300 g) female rats were used in this study. Specimens included renal pelvis and calyces. All specimens were evaluated under light microscope histopathologically. The concentrations of the receptor densities did not differ between the two groups. With the demonstration of the α receptors in rat kidneys and calyces, many receptor-based studies concerning both humans and rats can take place. Novel medication targeting these subtypes -in this matter α1A and α1D for renal pelvis and calyces- may be helpful for expulsive therapy and/or pain relief. With the demonstration of similar receptor densities between human and rat tissues, rat model may be useful for α-receptor trials for renal pelvis and calyces.
Subject(s)
Animals , Female , Humans , Kidney Calices/chemistry , Kidney Pelvis/chemistry , Models, Animal , Receptors, Adrenergic, alpha/analysis , Biopsy , Carcinoma, Renal Cell/chemistry , Immunohistochemistry , Kidney Neoplasms/chemistry , Nephrectomy , Rats, Wistar , Reproducibility of ResultsABSTRACT
OBJECTIVES: Although recent evidence has supported increased ureteral stone passage with selective alpha(1)-adrenergic receptor antagonists, no mechanistic study evaluating ureteral relaxation by alpha(1) antagonism has been reported to date. We evaluated whether the alpha-blocker doxazosin reduces spontaneous, and inhibits alpha(1)-agonist-induced ureteral contractility. Additionally, alpha-receptor subtypes in normal and obstructed human ureter were analyzed. METHODS: We exposed porcine ureters in organ tissue baths with 0.1, 1.0, or 10 microM doxazosin and recorded the tension for 90 minutes. After the initial treatment, a concentration-response curve of epinephrine or phenylephrine (1 nM to 10 microM) was generated. The experiment was repeated with the proximal, mid-, and distal ureter. The relative expression of the alpha 1A, 1B, and 1D receptor subtypes in normal and obstructed human ureters was analyzed using immunoblotting. RESULTS: Doxazosin reduced the spontaneous ureteral contractility rates in a concentration-dependent fashion by 23% to 34%. A more pronounced relaxation effect by doxazosin was evident when epinephrine was introduced to the tissues. In 1 and 10-microM doxazosin-pretreated tissues, epinephrine caused 89% and 100% relaxation, respectively. Phenylephrine-induced contractions were antagonized by doxazosin but not reversed to any relaxant function. No differential expression of alpha(1)-receptor subtypes was identified in the obstructed versus normal ureters. CONCLUSIONS: The results of our study have shown that alpha(1)-receptor blockade decreases ureteral contractility and inverses the effect of epinephrine, providing even greater relaxation. We hypothesize that alpha receptor blockade might relax the ureter and induce stone passage by way of epinephrine activation of beta receptors. Additional studies should be performed to validate this hypothesis and to compare various alpha(1)-receptor subtype antagonists.
Subject(s)
Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Doxazosin/pharmacology , Epinephrine/pharmacology , Muscle Contraction/drug effects , Muscle, Smooth/drug effects , Ureter/drug effects , Animals , Dose-Response Relationship, Drug , Epinephrine/antagonists & inhibitors , Humans , In Vitro Techniques , Muscle Relaxation/drug effects , Receptors, Adrenergic, alpha/analysis , Sus scrofa , Ureter/metabolism , Ureter/physiologyABSTRACT
The present study was performed to analyze in detail gender- and site-related alterations in the adrenergic signal transduction pathway of lipolysis in fat cells isolated from subcutaneous abdominal and visceral fat depots from severely obese patients. The study group consisted of 30 morbidly obese subjects (9 men and 21 women) aged 41.1+/-1.9 years, with a body mass index (BMI) of 54.7+/-1.7 kg/m2, who had undergone abdominal surgery. Protein levels of hormone-sensitive lipase (HSL) and adrenergic receptors (AR), as well as HSL activity and the lipolytic response to adrenergic agents were analyzed. Both fat depots had similar basal lipolysis, but the capacity of catecholamines to activate lipolysis was greater in visceral fat, both at AR and postreceptor levels. Basal lipolysis and lipolytic activity induced by dibutyryl cyclic AMP were higher in men than in women. However, the visceral depot of women showed a higher maximal stimulation by noradrenaline than that of men, in accordance with higher beta1- and beta3-AR protein levels. In conclusion, the main gender-related differences were located in the visceral depot, with women exhibiting a higher sensitivity to catecholamines associated with an increased provision of beta-AR, while men showed an enhanced lipolytic capacity at the postreceptor level.
Subject(s)
Abdominal Fat/metabolism , Adipose Tissue/metabolism , Intra-Abdominal Fat/metabolism , Lipolysis , Obesity, Morbid/metabolism , Adipocytes/metabolism , Adipose Tissue/pathology , Adult , Blotting, Western , Body Mass Index , Bucladesine/pharmacology , Colforsin/pharmacology , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Norepinephrine/pharmacology , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, beta/analysis , Sex Factors , Sterol Esterase/bloodABSTRACT
A literature search of PubMed documented publications and abstracts from proceedings of scientific meetings was made to review the available data on benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) and erectile dysfunction (ED) with a special focus on the role of alpha-adrenoceptors as critical mediators of pathophysiology. The reader is introduced to clinical results on the therapeutic potential of alpha-blockers alone and in combination with phosphodiesterase type 5 (PDE-5) inhibitors in the treatment of ED associated with LUTS/BPH. Epidemiological studies clearly show that an association exists between ED and LUTS/BPH. The severity of LUTS is correlated with the risk for ED. A significant number of LUTS/BPH patients are nonresponsive to the common ED treatment with PDE-5 inhibitors. As smooth muscle contractility is regulated by adrenoceptors in the corpus cavernosum, prostate and detrusor, the alpha-adrenoceptor system may be considered a common pathophysiological mediator in the development of ED and LUTS/BPH. Blockade of alpha-adrenoceptors for the treatment of BPH/LUTS may have the potential of improving sexual function. Conversely, PDE-5 inhibitors may exhibit positive effects in LUTS patients. Pilot studies on combination regimens of alpha-adrenoceptor antagonists and PDE-5 inhibitors have yielded encouraging results in LUTS patients with persistent ED. On the basis of pharmacological and clinical evidence, it is established that the alpha-adrenoceptor system plays an important role in the pathophysiology of ED and LUTS secondary to BPH. Larger trials on the combination of alpha-adrenoceptor antagonists with PDE-5 inhibitors are necessary to develop an integrated treatment approach for BPH/LUTS patients with comorbid ED.
Subject(s)
Erectile Dysfunction/physiopathology , Prostatic Hyperplasia/physiopathology , Receptors, Adrenergic, alpha/physiology , Urologic Diseases/physiopathology , Adrenergic alpha-Antagonists/therapeutic use , Aging/physiology , Drug Therapy, Combination , Erectile Dysfunction/drug therapy , Erectile Dysfunction/epidemiology , Humans , Male , Muscle, Smooth, Vascular/chemistry , Penile Erection/physiology , Phosphodiesterase Inhibitors/therapeutic use , Prostatic Hyperplasia/drug therapy , Receptors, Adrenergic, alpha/analysis , Risk Factors , Sexual Dysfunction, Physiological/drug therapy , Sexual Dysfunction, Physiological/physiopathology , Urologic Diseases/drug therapyABSTRACT
The primate cingulate cortex is structurally and functionally complex. Although no studies have investigated the regional densities of multiple neurotransmitter receptor systems, such information would be useful for assessing its functions and disease vulnerabilities. We quantified nine different receptors in five transmitter systems by in vitro autoradiographic mapping of the cingulate cortex of macaque monkeys with the aim to link cytoarchitectonic regions and functional specialization. Receptor mapping substantiated the subdivision of the cingulate cortex into anterior versus posterior regions. In anterior cingulate cortex (ACC) AMPA glutamatergic receptors and GABA(A) inhibitory receptors were present in significantly higher concentrations than the modulatory alpha-adrenergic and muscarinic receptors. These differences were absent in the posterior cingulate cortex (PCC). By contrast, NMDA receptor densities were significantly higher than AMPA receptor densities in PCC, but not in ACC. The midcingulate area 24' shared more features with ACC than PCC. This area was characterized by the highest ratios of NMDA receptors to alpha-adrenergic, muscarinic and 5-HT2 receptors among all cingulate regions. Compared to rostrocaudal divisions, the differences between dorsoventral subdivisions a-c were small in all regions of cingulate cortex, and only muscarinic and alpha-adrenergic receptor densities followed the degree of cytoarchitectonic differentiation. We conclude that multiple receptor mapping reveals a highly differentiated classification of cingulate cortex with a characteristic predominance of fast ionotropic excitatory and inhibitory receptors in ACC, but a strong and varied complement of NMDA and metabotropic receptors in PCC.
Subject(s)
Autoradiography , Gyrus Cinguli/anatomy & histology , Image Enhancement , Receptors, Neurotransmitter/analysis , Animals , Brain Mapping , Gyrus Cinguli/physiology , In Vitro Techniques , Macaca fascicularis , Male , Multivariate Analysis , Nerve Net/physiology , Neural Inhibition/physiology , Receptors, AMPA/analysis , Receptors, Adrenergic, alpha/analysis , Receptors, GABA-A/analysis , Receptors, Muscarinic/analysis , Receptors, N-Methyl-D-Aspartate/analysis , Receptors, Serotonin/analysis , Synaptic Transmission/physiologyABSTRACT
AIM AND METHODS: Enterochromaffin (EC) cells, interspersed throughout the gastrointestinal mucosa, provide most of the serotonin of the body and control intestinal motility, secretion and absorption. We purified EC cells from the rat ileum by a combination of elutriation and density gradient centrifugation in order to characterize the function of this important cell type. RESULTS: Immunostaining showed that there were 84% serotonin-positive cells in the highly enriched EC fraction as compared with 12% in unfractionated cells, yielding a approximately sevenfold enrichment. Serotonin measurements in the cell suspensions indicated a seven to 14-fold enrichment. Presence of alpha- and beta-adrenoreceptor isoforms, muscarinic M3 and gama-aminobutyric acid (GABA)-A receptors was confirmed by RT-PCR and cytochemistry. Increased expression of VMAT-1 and GABA-A mRNA was also shown by quantitative TaqMan PCR using EC cell RNA. Serotonin release in isolated EC cells was stimulated by noradrenaline, and to a smaller extent, by carbachol, while GABA addition was without effect. CONCLUSION: Our data provide a basis for a new approach to characterize receptors on this unique cell type.
Subject(s)
Enterochromaffin Cells/physiology , Ileum/cytology , Animals , Carbachol/metabolism , Cells, Cultured , Female , Gene Expression , Immunohistochemistry/methods , Intestinal Mucosa/physiology , Membrane Glycoproteins/metabolism , Membrane Transport Proteins/metabolism , Norepinephrine/metabolism , Polymerase Chain Reaction/methods , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptor, Muscarinic M3/analysis , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, beta/analysis , Receptors, GABA-A/analysis , Reverse Transcriptase Polymerase Chain Reaction/methods , Serotonin/analysis , Vesicular Biogenic Amine Transport Proteins , gamma-Aminobutyric Acid/metabolismSubject(s)
Coronary Disease/physiopathology , Hostility , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, beta/analysis , Coronary Artery Disease/metabolism , Coronary Artery Disease/physiopathology , Coronary Disease/metabolism , Coronary Vessels/physiology , Coronary Vessels/physiopathology , Humans , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/physiology , Risk Factors , Vasoconstriction/physiology , Vasodilation/physiologyABSTRACT
Alpha- and beta-adrenoceptors play an important role in the control of heart function. According to their molecular, biological, and pharmacological characteristics, they are subdivided into alpha(1)-, alpha(2)- and beta(1)-, beta(2)-, beta(3)-, beta(4)-adrenoceptors. In cardiac disease, there is often a selective downregulation of beta(1)-adrenoceptors associated with a relative increase in beta(2)- and alpha(1)-adrenoceptors. Functional imaging techniques like single-photon emission tomography (SPECT) and positron emission tomography (PET) provide the unique capability for non-invasive assessment of cardiac adrenoceptors. Radioligands with high specific binding to cardiac alpha- and beta-adrenoceptors suitable for radiolabelling are required for clinical studies. The non-selective beta-adrenoceptor antagonist [(11)C]CGP-12177 was used to quantify beta-adrenoceptor density using PET in patients with heart disease. New non-selective ligands (e. g. [(11)C]CGP-12388, [(18)F]CGP-12388, [(11)C]carazolol and [(18)F]fluorocarazolol) are currently evaluated; beta(1)-selective radioligands (e. g. [(11)C]CGP-26505, [(11)C]bisoprolol, [(11)C]HX-CH 44) and beta(2)-selective radioligands (e. g. [(11)C]formoterol, [(11)C]ICI-118551) were assessed in animals. None of them turned out as suitable for cardiac PET. Potential radioligands for imaging cardiac alpha(1)-adrenoceptors are based on prazosin. Whereas [(11)C]prazosin shows low specific binding to myocardium, its derivative [(11)C]GB67 looks more promising. The putative alpha(2)-adrenoceptor radioligand [(11)C]MK-912 shows high uptake in rodent myocardium but has not yet been evaluated in man. A number of radioligands were evaluated for assessing cardiac adrenoceptors using PET. New radioligands are needed to provide more insight into cardiac pathophysiology which may influence the therapeutic management of patients with cardiovascular disease.
Subject(s)
Heart/diagnostic imaging , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, beta/analysis , Carbon Radioisotopes , Humans , Radioligand Assay/methods , Radiopharmaceuticals/pharmacokinetics , Tomography, Emission-Computed , Tomography, Emission-Computed, Single-PhotonABSTRACT
Establishing the existence of alpha-adrenoceptor subtypes in isolated human gastroepiploic and omental arteries was the goal of the present study. Functional vascular reactivity of selective alpha(1)- and alpha(2)-adrenoceptor agonists and antagonists was studied, using a cannula inserting technique. Intraluminal administration of norepinephrine (NE), phenylephrine (PE) or BHT-933 caused a vasoconstrictive response in a dose-related manner. The relative potencies of the 3 agonists were almost the same in both arteries. NE-induced vasoconstrictions were significantly antagonized by either prazosin or rauwolscine. PE-induced responses were strongly inhibited by prazosin. BHT-933-induced constrictions were inhibited by rauwolscine. These results indicate that both alpha(1)- and alpha(2)-adrenoceptors exist in the human gastroepiploic and omental arteries.
Subject(s)
Arteries/chemistry , Gastroepiploic Artery/chemistry , Peritoneum/blood supply , Receptors, Adrenergic, alpha/analysis , Adrenergic alpha-1 Receptor Agonists , Adrenergic alpha-1 Receptor Antagonists , Adrenergic alpha-2 Receptor Agonists , Adrenergic alpha-2 Receptor Antagonists , Aged , Arteries/drug effects , Azepines/administration & dosage , Azepines/pharmacology , Catheterization , Dose-Response Relationship, Drug , Female , Gastroepiploic Artery/drug effects , Humans , In Vitro Techniques , Male , Middle Aged , Norepinephrine/administration & dosage , Norepinephrine/pharmacology , Phenylephrine/administration & dosage , Phenylephrine/pharmacology , Prazosin/pharmacology , Receptors, Adrenergic, alpha-1/analysis , Receptors, Adrenergic, alpha-2/analysis , Vasoconstriction/drug effects , Yohimbine/pharmacologyABSTRACT
BACKGROUND: Experiments were to characterize pharmacologically adrenergic receptors in human varicose veins to the natural transmitter norepinephrine and to an extract of Ruscus. METHODS: Greater saphenous veins and varicose tributaries from patients undergoing elective surgery for primary varicose disease and portions of greater saphenous veins from patients undergoing peripheral arterial reconstruction (control) were suspended for the measurement of isometric force in organ chambers. Concentration response curves were obtained to norepinephrine or the extract of Ruscus aculeatus in the absence and presence of selective antagonists of alpha, and alpha2 adrenergic receptors. RESULTS: Norepinephrine and Ruscus extract caused concentration-dependent contractions in all veins. Contractions to norepinephrine were greater in control veins than in varicose tributaries. Contractions to the extract were greater in varicose tributaries than in greater saphenous veins from varicose patients. Contractions to norepinephrine were reduced similarly by alpha and alpha2-adrenergic agonists in control and varicose veins but to a greater extent by alpha2-blockade in greater saphenous veins from varicose patients. Contractions to Ruscus extract were not reduced by alpha-adrenergic blockade in control veins but were reduced by alpha2-adrenergic blockade in varicose veins. CONCLUSIONS: These results suggest a differential distribution of alpha adrenergic receptors on greater saphenous veins from non-varicose patients compared to those with primary varicose disease. Venotropic agents from plant extract probably exert effects by way of multiple receptor and non-receptor mediated events.
Subject(s)
Receptors, Adrenergic, alpha/drug effects , Saphenous Vein/chemistry , Varicose Veins/metabolism , Adrenergic alpha-Agonists/pharmacology , Aged , Case-Control Studies , Female , Humans , Male , Middle Aged , Norepinephrine/pharmacology , Plant Extracts/pharmacology , Receptors, Adrenergic, alpha/analysis , Varicose Veins/surgery , Vasoconstriction/drug effectsABSTRACT
PURPOSE: To characterize the subtypes of alpha1- and alpha2-adrenoceptors in the human corpus cavernosum from patients undergoing sex change surgery. MATERIALS AND METHODS: Saturation and competition radioligand binding studies were performed for characterization at the protein level. Alpha1-adrenoceptors were labeled with [3H]prazosin and [3H]tamsulosin, while alpha2-adrenoceptors were labeled with [3H]RX 821002. Alpha1-adrenoceptor subtype mRNA was additionally determined by reverse-transcriptase polymerase chain reaction and RNase protection assays. RESULTS: Human corpus cavernosum expressed approximately 32 and approximately 22 fmol./mg. protein alpha1- and alpha2-adrenoceptors, respectively. Competition studies with the alpha1A-selective antagonists 5-methylurapidil and (+)-niguldipine and the alpha1D-selective BMY 7378 revealed a mixed alpha1A/alpha1B-adrenoceptor population with no evidence for alpha1D-adrenoceptor protein. In contrast alpha1D-adrenoceptors were readily detected at the mRNA level. Competition binding studies with the alpha2A-selective oxymetazoline and the alpha2B-selective prazosin and ARC 239 revealed a homogeneous population of alpha2A-adrenoceptors. CONCLUSIONS: We conclude that human corpus cavernosum expresses predominantly alpha1A-, alpha1B- and alpha2A-adrenoceptor protein; additionally the alpha1D-adrenoceptor is present at the mRNA level.
Subject(s)
Penis/chemistry , Receptors, Adrenergic, alpha/analysis , Adrenergic alpha-Antagonists/pharmacokinetics , Binding, Competitive , Disorders of Sex Development/surgery , Dose-Response Relationship, Drug , Humans , Idazoxan/analogs & derivatives , Idazoxan/pharmacokinetics , Male , Penis/metabolism , Penis/surgery , Prazosin/pharmacokinetics , Receptors, Adrenergic, alpha/metabolism , Sulfonamides/pharmacokinetics , TamsulosinABSTRACT
Recent reports characterizing the physiological properties of normal human labial acini are reviewed with particular emphasis on mechanisms related to fluid secretion. In contrast to the salivary glands of several experimental animals, human labial acinar cells do not appear to have a1-adrenergic receptors, substance P peptidergic receptors, or significant levels of Cl-/HCO3- exchange. Nor do they appear to secrete HCO3- in response to Ca2+ mobilizing stimuli. The data presently available indicates that fluid secretion by these glands is mainly under muscarinic control and is due to acinar Cl- secretion driven by a basolateral Na+ -K+ -2Cl- cotansporter.
Subject(s)
Ion Transport/physiology , Lip/anatomy & histology , Salivary Glands, Minor/metabolism , Signal Transduction/physiology , Animals , Calcium Channels/metabolism , Calcium Signaling/physiology , Carbonates/metabolism , Chloride Channels/metabolism , Chlorides/metabolism , Humans , Potassium Channels/metabolism , Receptors, Adrenergic, alpha/analysis , Receptors, Muscarinic/metabolism , Receptors, Neurokinin-1/analysis , Saliva/metabolism , Sodium Channels/metabolismABSTRACT
BACKGROUND: Chronic pulmonary hypertension can lead to compensatory changes in the right ventricle. In this study, the adaptive mechanisms of the right ventricle in the setting of pulmonary hypertension were assessed at the molecular and functional level using a canine model of monocrotaline pyrrole-induced pulmonary hypertension. METHODS: Animals underwent pulmonary artery catheterization to measure pulmonary hemodynamics before and 8 weeks after an injection of monocrotaline pyrrole, 3 mg/kg (n = 8) or placebo (n = 8) (controls). Systolic function was assessed with load-insensitive means (preload-recruitable stroke work). Myocardial biopsy specimens were collected to analyze membrane alpha1- and beta-adrenergic receptor density and adenylate cyclase activity. RESULTS: Eight weeks after injection, significant increases in pulmonary hemodynamic indices were noted in monocrotaline-injected dogs. Significant increases in right ventricular preload-recruitable stroke work were also observed in these animals compared with controls and occurred in association with significant increases in right ventricular alpha1- and beta-adrenergic receptor density and isoproterenol hydrochloride-stimulated adenylate cyclase activity. No significant differences in basal adenylate cyclase activity in the right ventricle were noted between the two groups. CONCLUSIONS: These data suggest that alterations in right ventricular function in the setting of chronic pulmonary hypertension may partially be due to changes in myocardial adrenergic receptor signaling.
Subject(s)
Adaptation, Physiological , Adenylyl Cyclases/metabolism , Hypertension, Pulmonary/physiopathology , Myocardium/metabolism , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, beta/analysis , Ventricular Function, Right/physiology , Animals , Chronic Disease , Dogs , Hemodynamics/physiology , Hypertension, Pulmonary/chemically induced , Monocrotaline/analogs & derivatives , Pulmonary Circulation/physiology , Stroke Volume/physiologyABSTRACT
Imidazoline receptors (29/30- and 45-kDa proteins) were quantitated in postmortem brains of patients with Alzheimer's disease (AD) by using immunoblotting techniques and a specific antiserum. Increased levels of the 29/30-kDa protein (30%), 45-kDa protein (36%) and glial fibrillary acidic protein (88%) were found in the frontal cortex of AD patients. These findings are in line with the reported higher density of imidazoline receptors labelled by [3H]idazoxan in AD brains, suggesting that these imidazoline receptor proteins are related to the I2-imidazoline receptor located in mitochondria of glial (astrocyte) cells.
Subject(s)
Alzheimer Disease/metabolism , Frontal Lobe/chemistry , Nerve Tissue Proteins/analysis , Receptors, Adrenergic, alpha/analysis , Receptors, Drug/analysis , Aged , Aged, 80 and over , Alzheimer Disease/pathology , Astrocytes/chemistry , Atrophy , Biomarkers/analysis , Female , Frontal Lobe/pathology , Glial Fibrillary Acidic Protein/analysis , Humans , Imidazoline Receptors , MaleSubject(s)
Prostatic Hyperplasia/complications , Urinary Retention/etiology , Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Prostatic Hyperplasia/pathology , Prostatic Hyperplasia/physiopathology , Receptors, Adrenergic, alpha/analysis , Urinary Retention/pathology , Urinary Retention/physiopathologyABSTRACT
OBJECTIVE: Our goal was to ascertain whether alterations in beta- and alpha-adrenergic receptor number and function (cyclic adenosine monophosphate production) occur during and after pregnancy. Because the actions of beta- and alpha2-adrenergic receptors tend to oppose each other, we hypothesized that there might be progressive, possibly reciprocal changes in these receptors during and after pregnancy. STUDY DESIGN: Blood was obtained from 21 women at 10, 20, 30, and 37 weeks of pregnancy and 3 to 4 months post partum. Lymphocyte beta- and platelet alpha2-adrenergic receptor number and affinity were quantified by radioligand binding studies, and receptor function was assessed by cyclic adenosine monophosphate generation assays. RESULTS: Although there were suggestions of progressive alterations in some of the variables studied, beta- and alpha2-adrenergic receptor number, affinity, and function did not manifest any statistically significant changes. CONCLUSION: Pregnancy did not produce marked alterations in beta-adrenergic receptor or alpha2-adrenergic receptor properties.
Subject(s)
Pregnancy/blood , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, alpha/physiology , Receptors, Adrenergic, beta/analysis , Receptors, Adrenergic, beta/physiology , Adult , Analysis of Variance , Blood Platelets/chemistry , Blood Platelets/cytology , Blood Platelets/physiology , Cyclic AMP/metabolism , Down-Regulation , Female , Humans , Iodine Radioisotopes , Longitudinal Studies , Lymphocytes/chemistry , Lymphocytes/cytology , Lymphocytes/physiology , Postpartum Period/blood , Postpartum Period/metabolism , Postpartum Period/physiology , Pregnancy/metabolism , Pregnancy/physiology , Receptors, Adrenergic, alpha/metabolism , Receptors, Adrenergic, beta/metabolismABSTRACT
1. Alterations in the cardiac alpha 1-adrenoceptor and its subtypes in hypothyroid rats were studied by radioligand binding assays and reverse transcription-polymerase chain reaction (RT-PCR). Hypothyroidism was created by feeding rats with 0.2% 2-thiouracil solution instead of daily drinking water for 20 days. 2. The density of cardiac alpha 1-adrenoceptors (Bmax) was increased from 67.5 +/- 4.3 fmol/mg in control rats to 81.1 +/- 7.2 fmol/mg (P < 0.05) in hypothyroid rats. 3. Compared with control rats, in hypothyroid rats the percentages of high-affinity sites for (+)-niguldipine and 5-methylurapidil were increased from 13.8 +/- 5.6 and 31.9 +/- 6.3%, respectively, to 24.9 +/- 7.3 and 45.5 +/- 2.4%, respectively (both P < 0.05), while those for BMY7378 were decreased from 37.2 +/- 8.9 to 23.8 +/- 8.4% (P < 0.05), respectively. The percentage of high-affinity sites for WB4101 was not significantly different in control and hypothyroid rats (43.3 +/- 9.1 and 39.4 +/- 3.6%, respectively). 4. Reverse transcription-PCR experiments revealed that the steady state levels of mRNA for alpha 1A- and alpha 1B-adrenoceptors were increased, while those for alpha 1D-adrenoceptor were decreased in the hearts of hypothyroid rats. 5. The concentration-contraction response curves for noradrenaline in the presence of a beta-adrenoceptor antagonist in control and hypothyroid rats showed that the maximal response was reduced from 344 +/- 58 to 200 +/- 23 mg, respectively (P < 0.05). 6. The data suggest that in hypothyroid rats the total number of cardiac alpha 1-adrenoceptors is increased. The change is subtype-selective, with levels of alpha 1A- and alpha 1B-adrenoceptors being increased and levels of alpha 1D-adrenoceptors being reduced. Furthermore, the positive inotropic response mediated by alpha 1-adrenoceptors is reduced in hypothyroid rats.
Subject(s)
Hypothyroidism/metabolism , Receptors, Adrenergic, alpha/metabolism , Tetralones , Adrenergic alpha-Antagonists/metabolism , Adrenergic alpha-Antagonists/pharmacology , Animals , Atrial Function , Binding, Competitive/drug effects , DNA Primers , Dihydropyridines/pharmacology , Dioxanes/pharmacology , Heart Atria/drug effects , Hypothyroidism/chemically induced , Hypothyroidism/physiopathology , Male , Myocardial Contraction/drug effects , Norepinephrine/pharmacology , Phenethylamines/metabolism , Piperazines/pharmacology , Polymerase Chain Reaction , Protein Binding/drug effects , RNA, Messenger/metabolism , Radioligand Assay , Rats , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, alpha/drug effects , ThiouracilABSTRACT
OBJECTIVE: To determine whether intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1-, or beta 2-adrenoceptors. DESIGN: The alpha1-adrenoceptor agonist phenylephrine, the alpha 2-adrenoceptor agonist clonidine, the beta 1-adrenoceptor agonist prenaterol and the beta 2-adrenoceptor agonist terbutaline were administered individually to a population of spontaneously active intrinsic cardiac neurons either locally (10 microL of 100 microM solution; eight dogs) or via the local arterial blood supply (0.1 mL of 100 microM solution; 20 dogs) in artificially ventilated, open chest anesthetized dogs. Neuronal and cardiac effects induced by each of the adrenergic agonists were also tested in the presence of an antagonist selective to each adrenoceptor subtype studied. MAIN RESULTS: The activity of intrinsic cardiac neurons was modified by at least one of the adrenoceptor agonists tested, and 34% of the spontaneously active neurons were affected by all four agonists. Alpha-adrenoceptor agonists either increased or decreased neuronal activity, depending on the population of neurons studied. On the other hand, the activity generated by intrinsic cardiac neurons was augmented by beta-adrenoceptor agonists. Ventricular contractile force increased when intrinsic cardiac neurons were excited by adrenoceptor agonists. The spontaneous activity generated by neurons was suppressed by beta-adrenoceptor, but not alpha-adrenoceptor, blockade. Neuronal and cardiovascular responses were no longer elicited by an agonist in the presence of its selective antagonist; they were elicited in the presence of antagonists to the other receptor subtypes studied. CONCLUSIONS: Intrinsic cardiac neurons involved in cardiac regulation possess alpha 1-, alpha 2-, beta 1- or beta 2-adrenoceptors. Intrinsic cardiac adrenergic neurons receive tonic inputs via beta-, but not alpha-, adrenoceptors. These data indicate that adrenergic blockade may affect cardiac function, in part, via modification of the intrinsic cardiac nervous system.
Subject(s)
Myocardium/cytology , Neurons/chemistry , Neurons/drug effects , Receptors, Adrenergic, alpha/analysis , Receptors, Adrenergic, alpha/drug effects , Receptors, Adrenergic, beta/analysis , Receptors, Adrenergic, beta/drug effects , Adrenergic alpha-Agonists/pharmacology , Adrenergic alpha-Antagonists/pharmacology , Adrenergic beta-Agonists/pharmacology , Adrenergic beta-Antagonists/pharmacology , Animals , Dogs , Female , Male , Phenylephrine/pharmacology , Receptors, Adrenergic, alpha-1/analysis , Receptors, Adrenergic, alpha-1/drug effects , Receptors, Adrenergic, alpha-2/analysis , Receptors, Adrenergic, alpha-2/drug effects , Receptors, Adrenergic, beta-1/analysis , Receptors, Adrenergic, beta-1/drug effects , Receptors, Adrenergic, beta-2/analysis , Receptors, Adrenergic, beta-2/drug effects , Terbutaline/pharmacologyABSTRACT
We have previously reported that compared with safflower oil diet, feeding a beef tallow diet leads to a greater accumulation of body fat by reducing sympathetic activities. The present study examined the effects of dietary fats consisting of different fatty acids on alpha1- and beta-adrenergic receptor binding in the hypothalamus and cerebral cortex. Male Sprague-Dawley rats were meal-fed isoenergetic diets based on safflower oil (rich in n-6 polyunsaturated fatty acids) or beef tallow (rich in saturated fatty acids) for 8 weeks. Binding affinities of the beta-adrenergic receptor in the hypothalamus and cortex were significantly lower in the beef tallow diet group, but those of the alpha1-receptor did not differ between the two groups. The polyunsaturated to saturated fatty acid (P/S) ratio and fluidities of plasma membranes in the hypothalamus and cortex were lower in the beef tallow diet group than in the safflower oil diet group. These results suggest that the beef tallow diet decreases membrane fluidity by altering the fatty acid composition of plasma membranes in the hypothalamus and cerebral cortex of rat. Consequently, beta-adrenergic receptor binding affinities in the brain were lower in rats fed the beef tallow diet than in rats fed the safflower oil diet. We recognized that there is possible link between the membrane fluidity and the changes in affinity of beta-adrenoceptors in rat brain.